Press Release
FDA: Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with...
Proscia: Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology KNOXVILLE, Tenn. and PHILADELPHIA — February 17, 2026 — NeuroScience Associates (NSA Labs), a specialized contract...
Seattle, WA – February 3, 2026 – RevealDx, a leader in AI tools for the characterization of lung nodules, announced FDA clearance of RevealAI-Lung. The company had previously announced MDR Certification in November of 2025. The RevealDx...
OptraSCAN: AI-powered digital pathology solution for AFB detection & bacillary grading at scale to support treatment response assessment and follow-up workflows. SAN JOSE, CA, UNITED STATES, February 5, 2026 /EINPresswire.com/...
Proscia: 100% of customers interviewed would buy again, citing trust for primary diagnosis at scale and a partnership they can count on PHILADELPHIA – February 4, 2026 – Proscia®, a software company advancing digital pathology for...
February 2, 2026 at 10:00 a.m. EET. Aiforia Technologies Plc today announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR. Aiforia® Gastric Cancer AI application is...
